Guixé V, Babul J
Departamento de Biología, Facultad de Ciencias, Universidad de Chile, Santiago.
Arch Biochem Biophys. 1988 Aug 1;264(2):519-24. doi: 10.1016/0003-9861(88)90317-7.
The aggregation states of Escherichia coli phosphofructokinase 2 (Pfk-2) and of a mutant enzyme (Pfk-2*) altered in the inhibitory allosteric site for MgATP were measured in the presence and in the absence of substrates and products of the reaction. When sucrose gradient ultracentrifugation experiments were performed in the absence of added ligands, both enzymes sedimented as dimers. Likewise, at low concentrations of both substrates (0.1 mM) the aggregation state of Pfk-2 and Pfk-2* corresponded to a dimer. However, in the presence of 1 mM MgATP alone, Pfk-2 sedimented as a tetramer, whereas Pfk-2* sedimented as a dimer. At a low fructose 6-phosphate concentration (0.1 mM) and an inhibitory concentration of MgATP (4 mM), Pfk-2 sedimented as a tetramer. However, at the same MgATP concentration but at a higher fructose-6-P concentration (1 mM), a condition under which Pfk-2 is not inhibited by the Mg-nucleotide complex, the enzyme sedimented as a dimer. Pfk-2* is not inhibited under these conditions and sedimented as a dimer in each case. Thus, the effectiveness of MgATP in promoting the aggregation of Pfk-2 and Pfk-2* parallels the inhibitability of the enzymes by the nucleotide complex. However, ATP4-, a potent inhibitor of Pfk-2 and Pfk-2* that binds to the catalytic site of the enzymes, had no effect upon their aggregation states. Possibly Pfk-2* is not able to form a tetramer because of an alteration in the regulatory site for the Mg-nucleotide complex.
在有和没有反应底物及产物存在的情况下,对大肠杆菌磷酸果糖激酶2(Pfk-2)以及在MgATP抑制性变构位点发生改变的突变酶(Pfk-2*)的聚集状态进行了测定。当在不添加配体的情况下进行蔗糖梯度超速离心实验时,两种酶均以二聚体形式沉降。同样,在两种底物浓度较低(0.1 mM)时,Pfk-2和Pfk-2的聚集状态也对应于二聚体。然而,仅在存在1 mM MgATP的情况下,Pfk-2以四聚体形式沉降,而Pfk-2以二聚体形式沉降。在果糖6-磷酸浓度较低(0.1 mM)且MgATP处于抑制浓度(4 mM)时,Pfk-2以四聚体形式沉降。然而,在相同的MgATP浓度但果糖-6-磷酸浓度较高(1 mM)的情况下,即在Pfk-2不被Mg-核苷酸复合物抑制的条件下,该酶以二聚体形式沉降。Pfk-2在这些条件下不被抑制,并且在每种情况下均以二聚体形式沉降。因此,MgATP促进Pfk-2和Pfk-2聚集的效力与核苷酸复合物对这些酶的抑制能力平行。然而,ATP4-作为Pfk-2和Pfk-2的强效抑制剂,可结合到酶的催化位点,但对它们的聚集状态没有影响。可能由于Mg-核苷酸复合物调节位点的改变,Pfk-2无法形成四聚体。